Search Results - "De Angelis, Federico"

Refine Results
  1. 1

    Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway by Miraglia, Erica, De Angelis, Federico, Gazzano, Elena, Hassanpour, Hossain, Bertagna, Angela, Aldieri, Elisabetta, Revelli, Alberto, Ghigo, Dario

    Published in Reproduction (Cambridge, England) (01-01-2011)
    “…Nitric oxide (NO), a modulator of several physiological processes, is involved in different human sperm functions. We have investigated whether NO may…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study by De Angelis, Federico, Tosti, Maria Elena, Capria, Saveria, Russo, Eleonora, D’Elia, Gianna Maria, Annechini, Giorgia, Stefanizzi, Caterina, Foà, Robin, Pulsoni, Alessandro

    Published in Leukemia research (01-12-2015)
    “…Highlights • SH after chemo-immunotherapy is a risk factor for iNHL patients. • Our study investigated incidence and risk factors for SH, infective…”
    Get full text
    Journal Article
  4. 4

    Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia by De Angelis, Federico, Breccia, Massimo

    Published in Oncology and therapy (2015)
    “…Acute promyelocytic leukemia (APL) is a molecularly well-defined disease, characterized by a specific chromosomal translocation; the improvement in biologic…”
    Get full text
    Journal Article
  5. 5

    Complete remission obtained with azacitidine in a patient with concomitant therapy related myeloid neoplasm and pulmonary mucormycosis by Capria, S, De Angelis, F, Gentile, G, Trisolini, S M, Brocchieri, S, Canichella, M, Chiusolo, P, Micozzi, A, Foà, R, Meloni, G

    “…Mucormycosis is the third cause of invasive mycosis after candidiasis and aspergillosis in AML patients, representing a poor prognostic factor associated with…”
    Get full text
    Journal Article
  6. 6

    TPO‐RAs in pITP: description of a case series and analysis of predictive factors for response by Mazzucconi, Maria Gabriella, Santoro, Cristina, Baldacci, Erminia, De Angelis, Federico, Chisini, Marta, Ferrara, Grazia, Volpicelli, Paola, Foà, Roberto

    Published in European journal of haematology (01-03-2017)
    “…Objective To report our experience concerning sustained response (SR) after TPO‐RA discontinuation in adult pITP patients and to identify possible predictive…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Is now the time for molecular driven therapy for diffuse large B-cell lymphoma? by Di Rocco, Alice, De Angelis, Federico, Ansuinelli, Michela, Foà, Robin, Martelli, Maurizio

    Published in Expert review of hematology (02-09-2017)
    “…Recent genetic and molecular discoveries regarding alterations in diffuse large B-cell lymphoma (DLBCL) deeply changed the approach to this lymphoproliferative…”
    Get more information
    Journal Article
  9. 9

    TPO ‐ RA s in pITP : description of a case series and analysis of predictive factors for response by Mazzucconi, Maria Gabriella, Santoro, Cristina, Baldacci, Erminia, De Angelis, Federico, Chisini, Marta, Ferrara, Grazia, Volpicelli, Paola, Foà, Roberto

    Published in European journal of haematology (01-03-2017)
    “…Abstract Objective To report our experience concerning sustained response ( SR ) after TPO ‐ RA discontinuation in adult pITP patients and to identify possible…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Splenectomy Is Still a Valid Option For Splenic Marginal Zone Lymphoma by Pulsoni, Alessandro, D'Urso, Pasqualina, D'Elia, Gianna Maria, Annechini, Giorgia, Stefanizzi, Caterina, Tricarico, Sara, Fama, Angelo, De Angelis, Federico, Foà, Robin

    Published in Blood (15-11-2013)
    “…Splenic marginal zone lymphoma (SMZL) is an indolent B-cell lymphoma characterized by splenomegaly, frequent moderate lymphocytosis with or without villous…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Treatment Of Early Stage Follicular Lymphoma With Involved Field Radiotherapy and Rituximab. Role Of Bcl-2 Molecular Monitoring by Pulsoni, Alessandro, Della Starza, Irene, D'Urso, Pasqualina, D'Elia, Gianna Maria, Annechini, Giorgia, Stefanizzi, Caterina, De Angelis, Federico, Tricarico, Sara, Grapulin, Lavinia, Cavalli, Marzia, FoÃ, Robin

    Published in Blood (15-11-2013)
    “…Stage I or II follicular lymphoma (FL) is an uncommon disease, representing only 20% of FL. Conventional treatment is represented by local radiotherapy (RT),…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Regression of a case of Multiple Myeloma with antiviral treatment in a patient with chronic HCV infection by Panfilio, Sara, D'Urso, Pasqualina, Annechini, Giorgia, D'Elia, Gianna Maria, De Angelis, Federico, Stefanizzi, Caterina, Pulsoni, Alessandro

    Published in Leukemia research reports (2013)
    “…Abstract We report a case of a 54 year old patient with Multiple Myeloma (MM) and chronic HCV infection. In 2005 MM was diagnosed and a chemotherapy was…”
    Get full text
    Journal Article
  19. 19
  20. 20